The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Workshop of the Carolinas 2024 | MPN disease biology: JAK2.V617F causes lymphopenia by blocking lymphopoiesis
In this video, Joseph Scandura, MD, PhD, Weill Cornell Medicine, New York, NY, briefly comments on his work investigating the disease biology of myeloproliferative neoplasms (MPNs). Dr Scandura and his team identified that the JAK2.V617F mutation causes lymphopenia by blocking lymphopoiesis. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Incyte, Abbvie, Constellation/Morphosys, SDP Oncology, Calico, Morphic, PharmaEssentia.
